Fierce BioTech: C₂N’s amyloid- and tau-detecting Alzheimer’s blood test outperforms other screening tests in two studies

Read more
Previous
Previous

Wall Street Journal: New Blood Tests Offer Possibly Early Detection of Cancer and Alzheimer’s

Next
Next

Lab Pulse: C₂N Diagnostics announces study confirming accuracy of test for Alzheimer’s diagnosis